In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Airborne Inc.

Biopharma Dealmaking Quarterly Statistics, Q4 2012

At $4.2 billion, biopharma financing in Q4 2012 showed a 36% increase over Q3 with FOPOs again dominating as the most popular deal type. With 34 finalized biopharma M&As, Q4 was the most active quarter of all 2012 for acquisitions. The 108 biopharma alliances completed had a combined potential deal value of almost $2 billion; Johnson & Johnson, with seven tie-ups, was the busiest pharmaco during Q4.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, December 2012

Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Bayer’s Schiff Nutrition Deal Expands Supplement Portfolio

Bayer Chairman Marijn Dekkers says Schiff’s products will complement its existing nutritionals business and provide marketing synergies with some OTCs. Schiff’s Move Free for joint health, MegaRed for heart health, Airborne for immunity and Digestive Advantage probiotics accounted for 70% of its fiscal 2012 sales.

Consumer Deals

Bayer’s Schiff Nutrition Deal Expands Supplement Portfolio

Bayer Chairman Marijn Dekkers says Schiff’s products will complement its existing nutritionals business and provide marketing synergies with some OTCs. Schiff’s Move Free for joint health, MegaRed for heart health, Airborne for immunity and Digestive Advantage probiotics accounted for 70% of its fiscal 2012 sales.

Consumer Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register